Sharon L Nichols1, Miriam C Chernoff2, Kathleen M Malee3, Patricia A Sirois4, Steven P Woods5, Paige L Williams2, Cenk Yildirim2, Dean Delis6, Betsy Kammerer7. 1. Department of Neurosciences, University of California, San Diego, La Jolla. 2. Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. 3. Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois. 4. Department of Pediatrics, Tulane University School of Medicine, New Orleans, Louisiana. 5. Department of Psychology, University of Houston, Texas. 6. Department of Psychiatry, University of California, San Diego, La Jolla. 7. Department of Psychiatry, Boston Children's Hospital, Massachusetts.
Abstract
BACKGROUND: Executive functions (EFs) are critical for management of life activities, but few studies have evaluated EFs in children and adolescents with perinatally acquired HIV (PHIV), who are at risk for problems in academics, behavior, and medication adherence. We compared EFs in youth with PHIV and in perinatally HIV-exposed but uninfected (PHEU) youth. METHODS: Four Delis-Kaplan Executive Function System (D-KEFS) subtests were administered to 173 youth with PHIV and 85 PHEU youth, aged 9 to <19 years, who were enrolled in the Pediatric HIV/AIDS Cohort Study (PHACS) Memory and Executive Functioning Study. Youth with PHIV, with or without history of a Centers for Disease Control and Prevention Class C (AIDS-defining) condition (PHIV/C [n = 45] and PHIV/non-C [n = 128], respectively), were compared with each other and with PHEU youth. Among youth with PHIV, associations with measures of current and past disease severity were evaluated using adjusted linear regression models. RESULTS: The PHIV/C group (mean age, 15.5 years), compared with the PHIV/non-C and PHEU groups (mean ages, 14.5 and 12.9 years, respectively), were significantly slower on the Inhibition and Color Naming/Reading Combined conditions of the Color-Word Interference subtest and made more errors on Inhibition; differences between the PHIV/C and PHEU groups persisted in adjusted models. No differences in adjusted means for fluency or problem-solving were found. The PHIV/non-C and PHEU groups did not differ on any measure. Associations of specific EF measures with HIV RNA viral load, CD4-positive T-lymphocyte percentage, and age at greatest disease severity were observed. CONCLUSIONS: Youth with PHIV and previous AIDS-defining conditions performed more poorly on some EF measures. Relationships of EF development with the degree and timing of disease severity require further study. Implications for long-term outcomes and interventions are important avenues for follow-up.
BACKGROUND: Executive functions (EFs) are critical for management of life activities, but few studies have evaluated EFs in children and adolescents with perinatally acquired HIV (PHIV), who are at risk for problems in academics, behavior, and medication adherence. We compared EFs in youth with PHIV and in perinatally HIV-exposed but uninfected (PHEU) youth. METHODS: Four Delis-Kaplan Executive Function System (D-KEFS) subtests were administered to 173 youth with PHIV and 85 PHEU youth, aged 9 to <19 years, who were enrolled in the Pediatric HIV/AIDS Cohort Study (PHACS) Memory and Executive Functioning Study. Youth with PHIV, with or without history of a Centers for Disease Control and Prevention Class C (AIDS-defining) condition (PHIV/C [n = 45] and PHIV/non-C [n = 128], respectively), were compared with each other and with PHEU youth. Among youth with PHIV, associations with measures of current and past disease severity were evaluated using adjusted linear regression models. RESULTS: The PHIV/C group (mean age, 15.5 years), compared with the PHIV/non-C and PHEU groups (mean ages, 14.5 and 12.9 years, respectively), were significantly slower on the Inhibition and Color Naming/Reading Combined conditions of the Color-Word Interference subtest and made more errors on Inhibition; differences between the PHIV/C and PHEU groups persisted in adjusted models. No differences in adjusted means for fluency or problem-solving were found. The PHIV/non-C and PHEU groups did not differ on any measure. Associations of specific EF measures with HIV RNA viral load, CD4-positive T-lymphocyte percentage, and age at greatest disease severity were observed. CONCLUSIONS: Youth with PHIV and previous AIDS-defining conditions performed more poorly on some EF measures. Relationships of EF development with the degree and timing of disease severity require further study. Implications for long-term outcomes and interventions are important avenues for follow-up.
Authors: Theodore D Ruel; Michael J Boivin; Hannah E Boal; Paul Bangirana; Edwin Charlebois; Diane V Havlir; Philip J Rosenthal; Grant Dorsey; Jane Achan; Carolyne Akello; Moses R Kamya; Joseph K Wong Journal: Clin Infect Dis Date: 2012-02-04 Impact factor: 9.079
Authors: Staci C Martin; Pamela L Wolters; Mary Anne Toledo-Tamula; Steven L Zeichner; Rohan Hazra; Lucy Civitello Journal: Dev Neuropsychol Date: 2006 Impact factor: 2.253
Authors: C Paula Lewis-de Los Angeles; Paige L Williams; Yanling Huo; Shirlene D Wang; Kristina A Uban; Megan M Herting; Kathleen Malee; Ram Yogev; John G Csernansky; Sharon Nichols; Russell B Van Dyke; Elizabeth R Sowell; Lei Wang Journal: Brain Behav Immun Date: 2017-01-10 Impact factor: 7.217
Authors: Reuben N Robbins; R Zimmerman; R Korich; J Raymond; C Dolezal; C J Choi; C S Leu; N Nguyen; K Malee; A Wiznia; E J Abrams; C A Mellins Journal: AIDS Care Date: 2019-06-07
Authors: Peter Torre; Jonathan S Russell; Renee Smith; Howard J Hoffman; Sonia Lee; Paige L Williams; Tzy-Jyun Yao Journal: Am J Audiol Date: 2020-01-31 Impact factor: 1.493
Authors: Patricia A Sirois; Miriam C Chernoff; Kathleen M Malee; Patricia A Garvie; Lynnette L Harris; Paige L Williams; Steven P Woods; Molly L Nozyce; Betsy L Kammerer; Cenk Yildirim; Sharon L Nichols Journal: J Pediatric Infect Dis Soc Date: 2016-12 Impact factor: 3.164
Authors: Kathleen M Malee; Miriam C Chernoff; Patricia A Sirois; Paige L Williams; Patricia A Garvie; Betsy L Kammerer; Lynnette L Harris; Molly L Nozyce; Cenk Yildirim; Sharon L Nichols Journal: J Acquir Immune Defic Syndr Date: 2017-08-01 Impact factor: 3.731
Authors: Jennifer A Pellowski; Devon M Price; Abigail D Harrison; Emily L Tuthill; Landon Myer; Don Operario; Mark N Lurie Journal: AIDS Behav Date: 2019-08
Authors: Rachel S Gruver; Sumaya Mall; Jane D Kvalsvig; Justin R Knox; Claude A Mellins; Chris Desmond; Shuaib Kauchali; Stephen M Arpadi; Myra Taylor; Leslie L Davidson Journal: New Dir Child Adolesc Dev Date: 2020-07-03
Authors: Thomas Struyf; Queen Dube; Elizabeth A Cromwell; Anna D Sheahan; Robert S Heyderman; Annelies Van Rie Journal: Eur J Paediatr Neurol Date: 2019-11-21 Impact factor: 3.140